首页|阿托伐他汀钙联合丁苯酞序贯疗法治疗急性缺血性脑血管病的效果及对神经功能的影响

阿托伐他汀钙联合丁苯酞序贯疗法治疗急性缺血性脑血管病的效果及对神经功能的影响

扫码查看
目的 探讨阿托伐他汀钙联合丁苯酞序贯疗法治疗急性缺血性脑血管病的临床效果及对神经功能的影响。方法 选取64例急性缺血性脑血管病患者为研究对象,采用简单化随机表法分为常规组和观察组,每组32例。常规组患者实施抗血小板聚集、扩张脑血管等常规对症治疗,观察组在常规组基础上实施阿托伐他汀钙联合丁苯酞序贯疗法治疗。比较两组患者治疗前后的美国国立卫生研究院卒中量表(NIHSS)评分、Barthel指数(BI)评分及治疗效果、不良反应发生情况。结果 与常规组的81。25% 比较,观察组治疗总有效率96。88% 明显更高(P<0。05)。治疗后,两组NIHSS评分和BI评分均较治疗前有所改善,且观察组NIHSS评分(5。13±0。67)分和BI评分(90。94±9。62)分明显优于常规组的(9。57±0。82)、(75。59±7。38)分(P<0。05)。与常规组的21。88% 比较,观察组的不良反应发生率3。13% 明显更低(P<0。05)。结论 阿托伐他汀钙联合丁苯酞序贯疗法治疗急性缺血性脑血管病具有显著的疗效及安全性,治疗后患者神经功能恢复良好,日常生活活动能力明显提高,具有临床研究的价值和意义。
Effect of atorvastatin calcium combined with butylphthalide sequential therapy in the treatment of acute ischemic cerebrovascular disease and its influence on neurological functions
Objective To explore the effect of atorvastatin calcium combined with butylphthalide sequential therapy in the treatment of acute ischemic cerebrovascular disease and its influence on neurological functions. Methods A total of 64 patients with acute ischemic cerebrovascular disease were selected and divided into a conventional group and an observation group by simplified random table method,with 32 cases in each group. The conventional group was given antiplatelet aggregation,cerebrovascular dilation and other conventional symptomatic treatments,while the observation group was given atorvastatin calcium combined with butylphthalide sequential therapy on the basis of the conventional group. The National Institutes of Health Stroke Scale (NIHSS) score and Barthel index (BI) score before and after treatment,therapeutic effect and occurrence of adverse reactions were compared between the two groups. Results Compared with 81.25% in the conventional group,the total effective rate of treatment in the observation group was significantly higher at 96.88% (P<0.05). After treatment,NIHSS score and BI score in both groups improved compared with those before treatment;the observation group had NIHSS score of (5.13±0.67) points and BI score of (90.94±9.62) points,which were significantly better than (9.57±0.82) and (75.59±7.38) points in the conventional group (P<0.05). Compared with 21.88% in the conventional group,the incidence of adverse reactions in the observation group was significantly lower at 3.13% (P<0.05). Conclusion Atorvastatin calcium combined with butylphthalide sequential therapy shows significant efficacy and safety for the treatment of acute ischemic cerebrovascular disease,and the patients' neurological function has recovered well after treatment,and the daily living ability has improved significantly. It has the value and significance of clinical research.

Atorvastatin calciumButylphthalideSequential therapyAcute ischemic cerebrovascular diseaseNeurological function

刘月、孙蜀宁

展开 >

110000 辽宁省金秋医院神经内科

阿托伐他汀钙 丁苯酞 序贯疗法 急性缺血性脑血管病 神经功能

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(23)